Oyekanmi Nash (36682669/2023)

Paper Title

Benzimidazole compound abrogates SARS-COV-2 receptor-binding domain (RBD)/ACE2 interaction In vitro.

Pubmed ID

36682669

Date

2023/02/28

Member Group

SPARCo Nigeria

Member Name

Oyekanmi Nash

First Author

Olaposi Omotuyi

First Author Affiliation

Institute for Drug Research and Development, S.E. Bogoro Center, Afe Babalola University, Ado-Ekiti, Nigeria

Last Author

Segun Fatumo

Last Author Affiliation

The African Computational Genomics (TACG) Research Group, MRC/UVRI, and LSHTM, Entebbe, Uganda